Showing results (391-400 of 462) with videos related to

Sort By:
Pageof 47
Nature Genetics|June 2, 2009
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinAnn K Daly, Peter T Donaldson, Pallav Bhatnagar, et al.
The Lancet. Respiratory Medicine|March 20, 2018
Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association studyDaniel B Hawcutt, Ben Francis, Daniel F Carr, et al.
British Journal of Cancer|May 19, 2020
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?Vincent Ting Fung Cheung, Tarun Gupta, Anna Olsson-Brown, et al.
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
Pharmacogenomics|August 13, 2015
Genome-wide association study of warfarin maintenance dose in a Brazilian sampleEsteban J Parra, Mariana R Botton, Jamila A Perini, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of warfarinMunir Pirmohamed, Girvan Burnside, Niclas Eriksson, et al.
BMJ Medicine|June 16, 2025
Use of sodium valproate and other antiseizure drug treatments in England and Wales: quantitative analysis of nationwide linked electronic health recordsCaroline E Dale, Rohan Takhar, Yat Yi Fan, et al.
Plos One|June 8, 2022
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countriesKathrin Blagec, Jesse J Swen, Rudolf Koopmann, et al.
Chemical Research in Toxicology|November 3, 2016
New Approaches to Investigate Drug-Induced HypersensitivityMonday O Ogese, Shaheda Ahmed, Ana Alferivic, et al.
Pharmacogenomics|September 13, 2012
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costsTalitha I Verhoef, William K Redekop, Rianne Mf van Schie, et al.
Pageof 47